Abstract
Editors' introduction In elderly men as in elderly women, endogenous estradiol may play an important role in age-related cognitive impairment. To explore the relation between estradiol, cognition, dementia, and cerebral atrophy, Muller and Geerlings performed a systematic literature review. In their review, the authors found that most studies in elderly men do not report significant associations between estradiol levels and cognitive performance, cognitive decline, dementia, or brain atrophy. Some studies, however, do imply that higher estradiol levels are potentially detrimental, although to the extent that a relation may exist, the magnitude of risk is likely small. Given the long preclinical phase of Alzheimer's disease (AD), it is difficult to infer causality, even in longitudinal studies with long follow-up. Muller and Geerling indicated that the relation between estradiol and vascular risk merits further study with respect to AD. In addition, they provide evidence that sex hormone binding globulin (SHBG) levels and aromatase activity are relevant to questions of AD pathogenesis. Introduction The impact of dementia on society and health care is a growing concern, given the increase of the elderly population. It is expected that with the increase of the elderly population, the prevalence of AD, the most common cause of dementia, will triple to 13 million people in the United States by 2050 [1].
| Original language | English |
|---|---|
| Title of host publication | Hormones, Cognition and Dementia |
| Subtitle of host publication | State of The Art and Emergent Therapeutic Strategies |
| Publisher | Cambridge University Press |
| Pages | 228-241 |
| Number of pages | 14 |
| ISBN (Electronic) | 9780511635700 |
| ISBN (Print) | 9780521899376 |
| DOIs | |
| Publication status | Published - 1 Jan 2009 |
Cite this
}
Endogenous estradiol and dementia in elderly men : The roles of vascular risk, sex hormone binding globulin, and aromatase activity. / Muller, Majon; Geerlings, Mirjam I.
Hormones, Cognition and Dementia: State of The Art and Emergent Therapeutic Strategies. Cambridge University Press, 2009. p. 228-241.Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
TY - CHAP
T1 - Endogenous estradiol and dementia in elderly men
T2 - The roles of vascular risk, sex hormone binding globulin, and aromatase activity
AU - Muller, Majon
AU - Geerlings, Mirjam I.
PY - 2009/1/1
Y1 - 2009/1/1
N2 - Editors' introduction In elderly men as in elderly women, endogenous estradiol may play an important role in age-related cognitive impairment. To explore the relation between estradiol, cognition, dementia, and cerebral atrophy, Muller and Geerlings performed a systematic literature review. In their review, the authors found that most studies in elderly men do not report significant associations between estradiol levels and cognitive performance, cognitive decline, dementia, or brain atrophy. Some studies, however, do imply that higher estradiol levels are potentially detrimental, although to the extent that a relation may exist, the magnitude of risk is likely small. Given the long preclinical phase of Alzheimer's disease (AD), it is difficult to infer causality, even in longitudinal studies with long follow-up. Muller and Geerling indicated that the relation between estradiol and vascular risk merits further study with respect to AD. In addition, they provide evidence that sex hormone binding globulin (SHBG) levels and aromatase activity are relevant to questions of AD pathogenesis. Introduction The impact of dementia on society and health care is a growing concern, given the increase of the elderly population. It is expected that with the increase of the elderly population, the prevalence of AD, the most common cause of dementia, will triple to 13 million people in the United States by 2050 [1].
AB - Editors' introduction In elderly men as in elderly women, endogenous estradiol may play an important role in age-related cognitive impairment. To explore the relation between estradiol, cognition, dementia, and cerebral atrophy, Muller and Geerlings performed a systematic literature review. In their review, the authors found that most studies in elderly men do not report significant associations between estradiol levels and cognitive performance, cognitive decline, dementia, or brain atrophy. Some studies, however, do imply that higher estradiol levels are potentially detrimental, although to the extent that a relation may exist, the magnitude of risk is likely small. Given the long preclinical phase of Alzheimer's disease (AD), it is difficult to infer causality, even in longitudinal studies with long follow-up. Muller and Geerling indicated that the relation between estradiol and vascular risk merits further study with respect to AD. In addition, they provide evidence that sex hormone binding globulin (SHBG) levels and aromatase activity are relevant to questions of AD pathogenesis. Introduction The impact of dementia on society and health care is a growing concern, given the increase of the elderly population. It is expected that with the increase of the elderly population, the prevalence of AD, the most common cause of dementia, will triple to 13 million people in the United States by 2050 [1].
UR - http://www.scopus.com/inward/record.url?scp=84927121090&partnerID=8YFLogxK
U2 - 10.1017/CBO9780511635700.025
DO - 10.1017/CBO9780511635700.025
M3 - Chapter
SN - 9780521899376
SP - 228
EP - 241
BT - Hormones, Cognition and Dementia
PB - Cambridge University Press
ER -